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INTRODUCTION
Prevalence of diabetes type II was increasing across the world. 
Studies showed that more than 220 million suffer from diabetes 
worldwide. [1] The WHO report in the year 2000, put the estimates at 
171 million. Which is expected to rise to 366 million in 2030.[2,3] Dia-
betes mellitus is a chronic disorder of glucose metabolism resulting 
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ABSTRACT
The incidence of type II diabetes is increasing across the world. Dietary modifications help the patients to control blood glucose. 
Traditional herbs and spices are commonly used for control of glucose among which cinnamon (肉桂 Ròu Guì; Cinnamomum cassia) 
has the greatest effect. Research has shown that adding cinnamon to diet can help to lower the glucose level. The aim of this study 
was to determine the effect of cinnamon on the glucose level in blood. This was a Randomized clinical trial in which 70 Patients with 
type II diabetes were assigned randomly two groups (35 in cinnamon and 35 in placebo group). The groups were matched in terms of 
body mass index (BMI), HbAlc and fasting blood sugar (FBS). Patients were treated with cinnamon and the placebo group was treated 
with placebo in addition to their routine treatment for 60 days. FBG levels and glycosylated hemoglobin of patients on the first day, and 
1 and 2 months after treatment were measured. Data were analyzed using t-test and paired t-test in Statistical Package for the Social 
Sciences (SPSS).16 software. The mean levels of FBS before, and 1 and 2 months after the intervention were 174 ± 59, 169 ± 43 and 
177 ± 45; respectively. The levels of HbAlc before and after the intervention in the cinnamon group were (8.9 ± 1.7 and 8.9 ± 1.6). 
There was no significant difference in FBS and glycosylated hemoglobin levels between the two groups (P = 0.738 and P = 0.87, 
respectively). Results showed that using certain amount of cinnamon for 60 days did not change the glucose level of diabetic patients. 
So, using cinnamon to type II diabetes patients cannot be recommended and more studies are needed in future.
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from dysfunction of pancreatic beta cells and insulin resistance. It 
is still a serious global health problem. The disease prevails in both 
genders and all age groups, so there is concern among the general 
public about its control and treatment. The therapeutic goal of dia-
betes control is reaching the normal level of blood glucose without 
hypoglycemia and without causing any disturbance in the daily life 
activities of patients. In type II diabetes, if the fasting blood sugar 
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(FBS) cannot be controlled by diet, oral drugs are used for the con-
trol of blood glucose which is associated with side effects resulting 
from long – term drug use.[4] Using complementary medicine among 
patients with diabetes is different but the major therapies used 
among the patients are nutritional supplements, herbal medicines, 
spiritual therapies, relaxation techniques and Yoga.[5] Studies showed 
that most of the diabetic patients use herbal medicines more than 
the other supplemental therapies because they believe that herbal 
medicines are natural, and healthy, whereas in poor quality and with 
improper use, they can be harmful and cause adverse effects.[6,7] 
Many studies confirmed that complementary medicine could be 
effective for diabetic patients they cause decrease in blood glucose 
levels by different mechanisms that could be helpful in patients’ 
care and for their better quality of life.[8]
Studies showed that spices such as cinnamon (肉桂 Ròu Guì; 
Cinnamomum cassia), and carnation, walnut, green tea, and mint 
have similar effects on insulin action and the most active of them 
is cinnamon.[6] Cinnamon is the most bioactive product.
Cinnamon is commonly used as a spice across the world and in 
Iran, its solution is used which is not toxic.[9] Several studies have 
been conducted to confirm the effect of cinnamon on decreasing 
the blood glucose of diabetic patients.[10] Khan[11] and Crawford[12] 
showed that cinnamon has anti- diabetic effect, but Steve Blevins[13] 
was not in agreement on the effect of cinnamon. In this respect, 
no study has been conducted in Iran on human subjects. Gheibi 
and Parvizi (2005) performed their study or rats and showed that 
cinnamon could decrease blood glucose in diabetes.[10] Therefore, 
keeping in mind the controversy on the effect of cinnamon in 
decreasing the blood glucose and due to the widespread use of 
cinnamon among Iranian people, this study was designed to see the 
effect of cinnamon on blood glucose in Type II diabetic individuals.
MATERIALS AND METHODS
Subjects
This study was a double blind randomized clinical trial that was 
done to determine the effect of cinnamon on the blood glucose of 
patients with diabetes type II in Mashhad. Samples were selected 
randomly and assigned to two groups of treatment and placebo. 
The study tools included demographic data, biochemistry auto 
analyzer, Pars Azmoon glucose kit and Bio-system kit. Validity 
of demographic form was confirmed by content validity and the 
other instruments used for measurement of blood glucose and gly-
cosylated hemoglobin were valid. To determine a power of 0.80, 
we calculated a sample size of 70, with α = 0.05. The sample size 
in each group was 35 and the study duration was 2 months. The 
inclusions criteria were: Age > 18 years, no pregnancy, no acute 
and severe stern in recent 8 weeks, not intake of herbs or other 
complementary cinnamon in recent 8 weeks, HbAlc > 7, 140 < FBS 
< 250, no allergy or sensitivity to cinnamon or other foods, no his-
tory of hemolytic anemia or hemoglobinopathy, no acute infection 
(pneumonia, urinary tract infection, otitis) and no insulin therapy.
Study design and dietary intervention
Subjects were selected based on the inclusion criteria among 
the patients who came to the (Endocrinology and Metabolism Cen-
ter, Mashhad University of Medical Science. The Samples selected 
and assigned randomly to two groups (treatment and placebo).
We randomized the patients by blocking (a designed tech-
nique). Investigators and subjects were blinded to group assign-
ment and to capsule content. Cinnamon and placebo were ground 
finely and put into capsules which could not be distinguished by 
color, odor, or taste. Each capsule contained 500 mg product.
After explaining the research objectives to the patients and 
taking their consent, demographic and related data were collected 
by interview and using patient’s medical file. Then, boxes of A and 
B that included 60 capsules of cinnamon (Cinnamomum cassia) 
or placebo, prepared by collage of pharmacy, were given to the 
patients. Patients had to use two capsules after breakfast and din-
ner with their drugs for first 30 days, then after 8h of fasting, 5 ml 
of blood was collected for glucose test. Then two capsules were 
given to patients for use for second 30 days and also, their blood 
glucose at the end of the second 30 days was evaluated.
Thirty and sixty days after using capsules, necessary infor-
mation such as change of drugs, cinnamon use, diet change, and 
Physical Activity was collected for the samples. Medications and 
diet of subjects were not changed during the study. Researcher 
used phone call for follow-up to ensure the use of capsules and 
recorded data about changing drug, diet and physical activity in 
a checklist. Researcher did not know the contents of the capsules 
until the end of the sampling and all the experiments were carried 
out by one laboratory.
Compliance to the supplementation protocol was supervised by 
a research technician who contacted the subjects once a week. Each 
subject was required to return the original bottle of their respective 
supplement for capsule counts and compliance was monitored by 
counting the unconsumed capsules each week.
Statistical methods and data analysis
Data are presented as Mean ± SD or percentage. Statistical 
analyses were performed using Statistical Package for the Social 
Sciences (SPSS) software (version 11.5). The normal distribu-
tion of the variable was checked by Kolmogorov–Smirnov test. 
Qualitative variables, such as physical activity, were analyzed 
using Chi-square test. For comparison of variables before and 
after the intervention within each group, paired t test was used. 
Significant differences between groups were determined by using 
an independent t test. Statistical significance was set at P < 0.05.
RESULTS
The sample consisted of 70 Type II diabetes patients di-
Table 1. Baseline characteristics of the study population*
Placebo (n=36)Cinnamon (n=35)Variable
54.7±8.153.7±9.7Age, years
28.7±427.1±3.2BMI
Gender (%)
33.3 (n=12)34.3 (n=12)Men
66.7 (n=24)65.7 (n=23)Women
Values are mans±SD or percentage; The groups did not differ with respect 
to any variable, P>0.05, BMI: Body mass index
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vided into two groups (35 cinnamon (肉桂 Ròu Guì; Cinnamo-
mum cassia) and 35 placebos). The mean age of patients was 
54.3 ± 8.9 years. Of them, 33.8 % (24) were males and the rest 
were females. Most of the patients in the groups were housekeepers 
(65.8% and 58.3%, respectively in cinnamon and placebo groups). 
The mean of body mass index (BMI) in cinnamon and placebo 
groups was 27.1 and 28.4, respectively [Table 1]. There was no 
significant different between FBS and glycosylated hemoglobin in 
the two groups before the intervention [Table 2]. Results showed 
that there was no significant difference between the mean of blood 
glucose in 30 and 60 days after the intervention in the two group 
(P > 0. 05) [Table 3]. There was no significant different between 
FBS and glycosylated hemoglobin in the two groups after the 
intervention (P > 0.05).
DISCUSSION
In this study, the blood glucose of type II diabetes patients did 
not decreased by using 1 g cinnamon (肉桂 Ròu Guì; Cinnamo-
mum cassia) during 60 days. There was no significant difference 
in FBS and glycosylated hemoglobin levels before and after the 
intervention between the two groups. In vitro studies have shown 
that cinnamon extract has increasing effect on Phosphorylation 
activity of insulin receptors and decreasing effect on tyrosine 
phosphatase activity, and so, it shows insulin-like properties.[14] 
Some studies have shown that cinnamon, like insulin hormone, 
inhibits glycogen synthase activity.[15]
Vance Chonbic et al., (2005) studied the effect of cinnamon 
on blood glucose of 25 type II diabetics during menopause and 
showed that there was no significant difference in terms of FBS, 
glycosylated hemoglobin, glucose tolerance test, insulin concen-
tration and serum lipids concentration on using 1.5 g cinnamon 
for 6 weeks.[16] Steave Belvin et al., (2007) reported that using 
cinnamon 1 g daily for 3 month had no significant effect on glu-
cose, lipid, and HbAlc levels in type II diabetics.[13] Justin et al., 
(2007) reported that using cinnamon 1 g daily had no significant 
effect on HbAlc of 72 type I diabetics and the result was similar 
to that of our study.[17] Soni et al., (2009) in one study showed that 
using 2g cinnamon had significant effect on the blood glucose 
of type II diabetics after 40 days and the findings confirmed that 
cinnamon is an effective material in decreasing the blood glucose 
of diabetic patients, which was not similar to our study results.[16] 
The difference could be attributed to the fact that in Soni’ s study, 
the experimental groups were formed by only males, so probably, 
hormonal difference and more consumption of cinnamon could 
be effective in the control of glucose, but it has not been proven 
yet. Khan et al., studied the effects of 1, 3, and 6 g day of whole 
cinnamon powder on FBG and serum lipids in 60 people with 
poorly controlled type II diabetes from Pakistan. After 40 days of 
supplementation, FBG decreased by 18-29%, cholesterol by 12-
26%, low density lipoprotein (LDL) cholesterol by 7-27%, and 
triacylglycerol decreased by 23-30%.[11] The result of our study was 
not similar with that of Khan and Craw ford, as it could be related 
to the difference in base of FBS, using no standard diet and short 
duration of intervention compared to the present study. [11,12] On 
the other hand, the capsules were packaged in a local store and use 
these capsules were not controlled in terms of purity. The other 
weakness of Crawford’s study in comparison with our study was 
lack of placebo group and blindness.
Our study result was similar to those of Justin,[18] and Steve 
Blevin but different from the results of Crawford, Khan, and Soni’s 
studies. Comparing the result of this study with those of others and 
considering their limitations, we can point as the limitations of 
the present study its duration (8 weeks) and dose of the cinnamon 
used (1 g per day). There are some studies with longer duration[19] 
and it would be better if we could have the possibility for continu-
ing the intervention. Which was impossible because subjects had 
time limitations to come to the study center (Endocrinology and 
Metabolism Center, Mashhad University of Medical Sciences) and 
extension of time would have led to limited compliance. There are 
some studies that used more than 1 g per day cinnamon and have 
reported significant effects,[11] and it would be better if we could 
have another group with higher dose of cinnamon for comparing 
the doses, which was impossible because of financial limitations.
CONCLUSION
Taking cinnamon (肉桂 Ròu Guì; Cinnamomum cassia) at 
a dose of 1 g daily for 30 and 60 days has no effect in decreas-
ing the blood glucose of type II diabetes patients. Based on the 
controversial information obtained on the effect of cinnamon in 
decreasing the blood glucose, it can be said that race, life style, 
BMI, type of drugs, and duration of taking cinnamon influence 
diabetes treatment. Many studies have been done reporting dif-
ferent results and it seems the effect of cinnamon was different 
in various populations. The results of this study showed that cin-
namon use at the study dose and duration was no effective and it 
is recommended to perform many studies in future with cinnamon 
at various doses and treatment duration.
Table 2. Comparison of means of FBS and HbAlc in patients’ before and after the intervention period in the two groups
Placebo group (n=36)Cinnamon group (n=35)Variables
DifferencesAfter (60 days)BeforeDifferencesAfter (60 days)Before
8±2.8151±38159±313±2.4174±59177±45FBS
1.4±0.188.3±1.38.4±1.40.03±0.018.9±1.68.9±1.7HbAlc
FBS: Fasting blood sugar; HbAlc: Hemoglobin A1c
Table 3. Comparison of means of FBS in patients’ 30 and 60 days after 
the intervention in the two groups
PlaceboCinnamonVariables
165±36169±43FBS after 30 days
164±34174±59FBS after 60 days
FBS: Fasting blood sugar
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